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The nucleolus is involved in regulating several aspects of stress responses and cell cycle arrest
through the tumor suppressor p53. Under normal conditions, p53 is a short-lived protein that
is present in cells at a barely detectable level. Upon exposure of cells to various forms of
exogenous stress, such as DNA damage, there is a stabilization of p53 which is then
responsible for an ensuing cascade of events. To further investigate the effect of p53 acti-
vation, we used a MS-based proteomics method to provide an unbiased, quantitative and
high-throughput approach for measuring the subcellular distribution of the proteome that is
dependent on p53. The spatial proteomics method analyses a whole cell extract created by
recombining differentially labeled subcellular fractions derived from cells in which proteins
have been mass labeled with heavy isotopes [Boisvert, F.-M., Lam, Y. W., Lamont, D.,
Lamond, A. I., Mol. Cell. Proteomics 2010, 9, 457–470]. This was used here to measure the
relative distribution between cytoplasm, nucleus and nucleolus of around 2000 proteins in
HCT116 cells that are either expressing wild-type p53 or null for p53. Spatial proteomics also
facilitates a proteome-wide comparison of changes in protein localization in response to a
wide range of physiological and experimental perturbations. We used this method to study
differences in protein localization in HCT116 cells either with or without p53, and studied the
differences in cellular response to DNA damage following treatment of HCT116 cells with
etoposide in both p53 wild-type and null genetic backgrounds.
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1 Introduction
The nucleolus is involved in regulating several aspects of
stress responses and cell cycle arrest through the tumor
suppressor p53. The p53 tumor suppressor gene is mutated
in approximately 50% of human tumors and plays an
important role in the response to genotoxic stress and
hypoxia [1]. Under normal conditions, p53 is a short-lived
protein that is present in cells at a barely detectable level.
Upon exposure of cells to various forms of exogenous stress,
such as DNA damage, heat shock, hypoxia, etc., there is a
stabilization of p53 which is then responsible for an ensuing
cascade of events, resulting in either cell cycle arrest or in
apoptosis. Accumulation of p53 in the cell induces the p21-
mediated inhibition of cyclin D/cdk4 and cyclinE/cdk2,
resulting in cell cycle arrest in G1. The stability of the p53
protein in mammals is primarily regulated in non-trans-
formed cells by the interplay of two proteins, hdm2 and
p14Arf in humans (the equivalent mouse proteins are
mdm2 and p19Arf) [2]. Hdm2 functions as a speciﬁc E3
ubiquitin ligase for p53, resulting in a low level of p53 under
normal growth conditions due to proteasome-mediated
degradation of ubiquitin-conjugated p53. A variety of
Abbreviations: Cyto, cytoplasm; Eto, etoposide; FDR, false
discovery rate; No, nucleoli; Nuc, nuclei
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increase expression of Arf, which then associates with hdm2
to inhibit the ubiquitination, nuclear export and subsequent
degradation of p53. It has been proposed that Arf
physically sequesters hdm2 in nucleoli (No), thereby
relieving nucleoplasmic p53 from hdm2-mediated degrada-
tion [3]. Arf is predominantly a nucleolar protein and might
also regulate ribosome biogenesis by retarding the
processing of early 47S/45S and 32S rRNA precursors,
perhaps through interaction with B23 [4]. Exposure
of cells to various forms of stress, such as DNA damage,
heat shock and aberrant ribosome biogenesis results in an
increase in p53 and cell cycle arrest. Thus, the nucleolus acts
as a sensor for cellular stress signals through p53 stabili-
zation [5].
SILAC, or stable isotope labeling with amino acids in cell
culture, is the use of stable isotopic atoms along with MS for
quantitative MS analysis [6, 7]. This method allows quanti-
tative analyses of proteins by comparison of the mass of
light and heavier forms of the same peptide from a given
protein, arising from the presence of heavier, stable
isotopes, such as
13C,
2H and
15N. These stable isotopes are
incorporated in proteins by in vivo labeling, i.e. growing the
cells in specialized media where speciﬁc amino acids,
typically arginine and lysine, are replaced with correspond-
ing heavy isotope-substituted forms in which either all
carbons or combinations of carbons, hydrogens or
nitrogens are isotope labeled [8]. Cleavage at the substituted
arginine or lysine by trypsin generates a peptide with a shift
in mass relative to the control (i.e. unsubstituted) peptide
and this can be easily resolved by MS. The ratio of inten-
sities of the ‘‘light’’ and ‘‘heavy’’ peptide signals identiﬁed by
MS directly correlates with the relative amount of the
cognate protein from each sample. This method has been
widely used for both relative quantiﬁcation of protein
levels after exposure of cells to drugs and inhibitors and for
the identiﬁcation of speciﬁc protein interaction partners
[9–12].
Using a quantitative proteomic approach to measure the
protein content in different cellular fractions, we utilized a
technique called spatial proteomics that measures the
cellular distribution of thousands of proteins using a
combination of cellular fractionation and MS [13]. This
method involves ﬁrst culturing cells with SILAC medium to
ensure that proteins are fully labeled [8]. The SILAC incor-
porated cells are then separated into fractions, e.g. the
cytoplasm (Cyto), nucleus and nucleolus that are recom-
bined such that each fraction has a distinct isotope signa-
ture. The labeling thus allows quantiﬁcation of the relative
abundance of peptides originating from subcellular fraction
and was used to study the relative distribution of the
proteome between the Cyto, nucleus and nucleolus [13]. We
hypothesized that we could use this technique also to
determine the difference in protein localization caused by
speciﬁc gene knockouts, such as here between wild-type and
p53 null cells. We then identiﬁed and quantiﬁed the change
in proteome localization induced by activation of the
DNA damage response in either the presence or absence, of
p53.
2 Materials and methods
2.1 Cell culture
The human colon carcinoma cell line HCT116 that are
either wild-type (p53
1/1) or p53 null (p53
/) were cultured
as adherent cells in DMEM (Invitrogen, custom order)
depleted of arginine and lysine. The DMEM was supple-
mented with 10% fetal bovine serum dialyzed with a cut-off
of 10kDa (Invitrogen, 26400-044), 100U/mL penicillin/
streptomycin, 2mM L-glutamine. Arginine and lysine were
added in either light (Arg0, Sigma, A5006; Lys0, Sigma,
L5501), medium (Arg6, Cambridge Isotope Lab (CIL), CNM-
2265; Lys4, CIL, DLM-2640) or heavy (Arg10, CIL, CNLM-
539; Lys8, CIL, CNLM-291) form to a ﬁnal concentration of
28mg/mL for arginine and 49mg/mL for lysine. Cells
were tested for full incorporation of the label after six
passages.
2.2 Cell fractionation
Cyto, nuclei (Nuc) and No were prepared from HCT116 cells
using a method originally described in [14]. Brieﬂy, cells
were washed three times with PBS, resuspended in 5mL
buffer A (10mM HEPES–KOH [pH 7.9], 1.5mM MgCl2,
10mM KCl, 0.5mM DTT), and dounce homogenized ten
times using a tight pestle. Dounced Nuc were centrifuged at
228g for 5min at 41C. The supernatant represents the
cytoplasmic fraction. The nuclear pellet was resuspended in
3mL 0.25M sucrose, 10mM MgCl2, and layered over 3mL
0.35M sucrose, 0.5mM MgCl2 and centrifuged at 1430g
for 5min at 41C. The clean, pelleted Nuc were resuspended
in 3mL 0.35M sucrose, 0.5mM MgCl2 and sonicated for
610s using a microtip probe and a Misonix XL 2020
sonicator at power setting 5. The sonication was checked
using phase contrast microscopy, ensuring that there were
no intact cells and that the No were readily observed as
dense, refractile bodies. The sonicated sample was then
layered over 3mL 0.88M sucrose, 0.5mM MgCl2 and
centrifuged at 2800g for 10min at 41C. The pellet
contained the No, while the supernatant consisted of the
nucleoplasmic fraction. The No were then washed by
resuspension in 500mL of 0.35M sucrose, 0.5mM MgCl2,
followed by centrifugation at 2000g for 2min at 41C.
Proteins were quantiﬁed using the Quant-IT protein assay
(Invitrogen) and measured using a Qubit (Invitrogen).
Equal amounts of total protein from each fraction were then
recombined to recreate a whole-cell extract, but with
Cyto, Nuc and No arising from cells with different isotopic
labels.
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Equal amounts (10mg) of proteins from each fraction were
boiled in the loading buffer, and then separated by one-
dimensional SDS-PAGE (4–12% Bis-Tris Novex mini-gel,
Invitrogen) and either visualized by Coomassie staining
(SimplyBlue SafeStain, Invitrogen) or transferred to nitro-
cellulose prior to western blotting with a rabbit polyclonal
RPL11 antibody (abcam) or a mouse monoclonal B23-
nucleophosmin antibody (Sigma).
2.4 Immunoﬂuorescence
Cells were grown on glass coverslips and ﬁxed with 3.7%
paraformaldehyde in cytoskeleton (CSK, 10mM PIPES pH
6.8, 10mM NaCl, 300mM sucrose, 3mM MgCl2 and 2mM
EDTA) buffer for 10min. Cells were then permeabilized in
PBS containing 0.5% Triton X-100 for 10min, and then
labeled with antibodies recognizing RPL11 (Abcam). After
washing with PBS containing 0.1% Triton X-100 and PBS,
cells were then labeled with a secondary antibody coupled to
Alexa 594 (Molecular Probes) and mounted on slides with
Vectashield (Vector Laboratories) containing DAPI. Fluor-
escence imaging was performed on a DeltaVision Spectris
wideﬁeld deconvolution microscope (Applied Precision),
using a CoolMax charge-coupled device camera (Roper
Scientiﬁc). Cells were imaged using a 60 NA 1.4
Plan-Apochromat objective (Olympus) and the appropriate
ﬁlter sets (Chroma Technology), with 20 optical sections
of 0.5mM each acquired. SoftWorX software
(Applied Precision) was used for both acquisition and
deconvolution.
2.5 Gel electrophoresis and in-gel digestion
The reconstituted cell fractions were reduced in 10mM DTT
and alkylated in 50mM iodoacetamide prior to boiling in
loading buffer, and then separated by one-dimensional SDS-
PAGE (4–12% Bis-Tris Novex mini-gel, Invitrogen) and
visualized by colloidal Coomassie staining (Novex, Invitro-
gen). The entire protein gel lanes were excised and cut into
eight slices each. Every gel slice was subjected to
in-gel digestion with trypsin [15]. The resulting tryptic
peptides were extracted by 1% formic acid, then 100%
ACN, lyophilized in a speedvac and resuspended in 1%
formic acid.
2.6 LC-MS/MS
Trypsin-digested peptides were separated using an Ultimate
U3000 (Dionex) nanoﬂow LC-system consisting of a solvent
degasser, micro and nanoﬂow pumps, ﬂow control module,
UV detector and a thermostated autosampler. Ten microliter
of sample (a total of 2mg) was loaded with a constant ﬂow of
20mL/min onto a PepMap C18 trap column (0.3mm
id5mm, Dionex). After trap enrichment peptides were
eluted onto a PepMap C18 nano column (75mm15cm,
Dionex with a linear gradient of 5–35% solvent B (90% ACN
with 0.1% formic acid) over 65min with a constant ﬂow of
300nL/min. The HPLC system was coupled to an LTQ
Orbitrap XL (Thermo Fisher Scientiﬁc) via a nano ES ion
source (Proxeon Biosystems). The spray voltage was set to
1.2kV and the temperature of the heated capillary was set to
2001C. Full-scan MS survey spectra (m/z335–1800) in
proﬁle mode were acquired in the Orbitrap with a resolution
of 60000 after accumulation of 500000 ions. The
ﬁve most intense peptide ions from the preview scan
in the Orbitrap were fragmented by collision-induced
dissociation (normalized collision energy 35%, activation Q
0.250 and activation time 30ms) in the LTQ after the
accumulation of 10000 ions. Maximal ﬁlling times were
1000ms for the full scans and 150ms for the MS/MS scans.
Precursor ion charge state screening was enabled and all
unassigned charge states as well as singly charged species
were rejected. The dynamic exclusion list was restricted to a
maximum of 500 entries with a maximum retention period
of 90s and a relative mass window of 10ppm. The lock mass
option was enabled for survey scans to improve mass
accuracy [16]. Data were acquired using the Xcalibur
software.
2.7 Quantiﬁcation and bioinformatic analysis
Quantitation was performed using the program
MaxQuant version 1.0.13.13 [17, 18]. The derived peak list
generated by Quant.exe (the ﬁrst part of MaxQuant) was
searched using MASCOT (Matrix Sciences, London, UK) as
the database search engine for peptide identiﬁcations
against the International Protein Index (IPI) human protein
database version 3.37 containing 69290 proteins, to which
175 commonly observed contaminants and all the reversed
sequences had been added. The initial mass tolerance was
set to 7ppm. and MS/MS mass tolerance was 0.5Da.
Enzyme was set to trypsin/p with two missed cleavages.
Carbamidomethylation of cysteine was searched as a ﬁxed
modiﬁcation, whereas N-acetyl protein and oxidation of
methionine were searched as variable modiﬁcations. Iden-
tiﬁcation was set to a false discovery rate (FDR) of 1%. To
achieve reliable identiﬁcations, all proteins were accepted
based on the criteria that the number of forward hits in the
database was at least 100-fold higher than the number of
reverse database hits, thus resulting in a FDR of less than
1%. A minimum of two peptides were quantiﬁed for each
protein. Protein isoforms and proteins that cannot be
distinguished based on the peptides identiﬁed are
grouped and displayed on a single line with multiple
International Protein Index numbers (see Supporting
Information tables).
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HCT116 p53
1/1 is a human colon carcinoma cell line,
which contains a wild-type p53 gene, whereas the HCT116
p53
/ is a p53 knockout cell line derived from HCT116
p53
1/1 by homologous recombination [19]. Cells were
grown in three different media for SILAC labeling,
containing arginine and lysine, either with the normal
‘‘light’’ isotopes of carbon and nitrogen (i.e.
12C
14N) (light),
or L-arginine-
13C6
14N4 and L-lysine-
2H4 (medium) or L-argi-
nine-
13C6-
15N4 and L-lysine-
13C6-
15N2 (heavy). Separate
Cyto, Nuc and No fractions were isolated from each labeled
cell population as previously described [14]. Equal amounts
of total protein from each fraction were then recombined to
recreate a whole cell extract, but with Cyto, Nuc and No
arising from cells with different isotope labels (Fig. 1A). The
recombined whole cell extract mixture was solubilised with
the loading buffer, proteins separated using SDS-PAGE and
the resulting gel cut into eight equal pieces, trypsin digested
and analyzed by LC-MS/MS using an LTQ Orbitrap [20].
The resulting ratios between light, medium and heavy
isotopic forms for each peptide identiﬁed were quantiﬁed
using MaxQuant [17]. The separate ratio values for each
peptide in a given protein were averaged to provide a
measure of the relative distribution for the protein between
the respective Cyto, Nuc and No compartments (Fig. 1A).
Two independent experiments were performed of the whole
spatial proteomics procedure using separate preparations of
isotope-labeled HCT116 cells (Figs. 1B and C). We named
each repeat WTa and WTb for the wild-type cells, and p53a
Figure 1. Spatial Proteomics Method (A)
Human colon carcinoma HCT116 cells were
grown in DMEM containing either the
normal ‘‘light’’ isotopes of carbon and
nitrogen (i.e.
12C
14N) (light) or L-argini-
ne-
13C6
14N4 and L-lysine-
2H4 (medium) or
L-arginine-
13C6-
15N4 and L-lysine-
13C6-
15N2
(heavy). Separate cytoplasmic, nuclear and
nucleolar fractions were isolated from each
labeled cell population. Equal amounts of
total protein from each fraction were then
recombined to recreate a whole cell extract,
but with Cyto, Nuc and No arising from cells
with different isotope labels. The recom-
bined whole cell extract mixture was solu-
bilized with loading buffer, proteins
separated using SDS-PAGE and the resulting
gel cut into eight equal pieces, trypsin
digested and analyzed by LC-MS/MS using
an LTQ Orbitrap. To compare different
genotype or conditions, cells are analyzed as
described above, and changes in localization
under different conditions will result in
changes in SILAC ratios under normal
conditions (A) and following treatment or
when studying a different condition (C).
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peptides were quantiﬁed, corresponding to 1958 proteins
(i.e. protein isoform groups, see Section 2) using a mini-
mum of two peptides identiﬁed and a FDR of 1%. The
distribution ratio between the three cellular compartments
derived for each protein was calculated as a median of the
values for all peptides identiﬁed for each protein (Support-
ing Information Table 1).
To check whether any differences observed in proteome
localization dependent upon p53 arose because of biologi-
cally relevant changes and not simply due to experimental
variation (e.g. in reproducibility of either MS or fractionation
procedures), statistical evaluation of the repeat data sets was
carried out. The data show a Pearson correlation of 0.92 and
0.93 for the nucleoplasmic/cytoplasmic and the nucleolar/
cytoplasmic ratios, respectively between repeats of the wild-
type cells (i.e. WTa versus WTb). A similar reproducibility
was observed for the p53 knock-out cells, with Pearson
correlations of 0.93 and 0.98 for the nucleoplasmic/cyto-
plasmic and the nucleolar/cytoplasmic ratios, respectively,
between repeats using the p53 knock-out cells. Interestingly,
there is little variation between the wild-type and the p53
knock-out cells in terms of the overall proteome localization
within the cell. The Pearson correlation between the p53
1/1
and
/ cells is 0.91 and 0.94 for the nucleoplasmic/cyto-
plasmic and the nucleolar/cytoplasmic ratios, respectively,
indicating there are little or no p53-dependent differences in
subcellular protein localization. This is illustrated in the
respective plots showing comparison of the subcellular
protein distribution of WT cells according to their nucleo-
plasmic/cytoplasmic ratio (Fig. 2A) and nucleolar/cyto-
plasmic ratio (Fig. 2B) and of the p53 knock-out cells
according to their nucleoplasmic/cytoplasmic ratio (Fig. 2C)
and nucleolar/cytoplasmic ratio (Fig. 2D). The proteins were
sorted according to their log base two WT ratios from
highest to lowest, and the proteins are displayed in the same
order in the p53 knock-out cells to underline the differences.
Although there are minor variations between the two cell
lines with regards to proteome localization, only 40 proteins
had a ratio difference greater than two (Supporting Infor-
mation Table 2). Interestingly, 18 of those 40 proteins are
involved directly in pre-mRNA splicing, which could suggest
that it reﬂects a genuine difference between the two cell
genotypes. This difference in proteins involved in mRNA
processing has also been observed previously in a p53-
dependent protein expression proﬁling study of the HCT116
cells [21]. We conclude that variations from the fractionation
and MS procedure have at most a small effect on the values
measured and we conclude further that there are only minor
differences in subcellular protein localization resulting
directly from p53 genotype.
Next, we used spatial proteomics to compare the cellular
localization of the proteome in HCT116 cells following
exposure to the topoisomerase II inhibitor etoposide (Eto),
which induces DNA damage and double strand breaks. We
checked whether we could observe any differences in
subcellular localization following DNA damage that would
be dependent on p53. The data show a moderate effect on
protein localization in wild-type cells with Pearson correla-
tions of 0.88 and 0.85 for the nucleoplasmic/cytoplasmic
and the nucleolar/cytoplasmic ratios, respectively, between
samples when wild-type cells were treated with Eto. This is
illustrated in the respective scatter plots showing the loca-
lization of proteins of wild-type cells (Fig. 3A, blue) and
showing the effect of Eto on protein localization (Fig. 3B,
red). For the p53 knock-out cells (Fig. 3C, blue), we found a
Figure 2. Comparison of
HCT116 p53
1/1 and p53
/
cells. Graph represents the
proteins (x axis) versus the log
base two of the SILAC ratio
corresponding to the (A),
(C) nucleoplasmic/cytoplasmic
(medium over light, M/L) or the
(B), (D) nucleolar/cytoplasmic
(heavy over light, H/L) in the
y axis. The plots correspond to
the cellular distribution of
proteins from WT cells (A and
B) or from the p53 knock-out
cells (C and D). The order of the
proteins shown is sorted
according to their localization
ratio from the WT cells, and the
proteins are displayed in the
same order in the p53 knock-
out cells.
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0.89 for the nucleoplasmic/cytoplasmic ratio (Fig. 3D, red).
However, the effect on the nucleolar localization was much
closer to the differences between repeats of the experiment
with a Pearson correlation of 0.93 for the nucleolar/cyto-
plasmic ratios between samples when cells were treated with
Eto. This suggests that Eto induces a signiﬁcant change in
the protein content of the nucleolus, and that this change is
at least in part dependent on the presence of wild-type p53.
This increased segregation of nucleolar proteins within the
nucleolus following stress is consistent with the previous
observations [5].
These spatial proteomics data provide new evidence
showing that p53 is involved in the response to DNA
damage in the nucleolus. We analyzed further which
proteins speciﬁcally showed a difference in localization in
p53 null cells. We found 123 proteins that after DNA
damage had more than a twofold difference between the
wild-type and the p53 knock-out cells (Supporting Infor-
mation Table 3, p.1). The most striking group of proteins
identiﬁed was the ribosomal proteins, which show a clear
change in cellular localization following DNA damage in
wild-type cells (Fig. 4A and Supporting Information Table 3,
p.2). These data are consistent with an inhibition of the
nucleolar import of ribosomal proteins. Interestingly, this
effect is not observed in the absence of p53 (Fig. 4C), indi-
cating that p53 is directly or indirectly involved in the
inhibition of ribosomal protein import following cellular
stress (Fig. 4D). There was no difference between the p53
wild-type and null cells in the localization of ribosomal
proteins in the absence of DNA damage (Fig. 4B). We also
observed a difference between the nucleoplasm and the
nucleolus. If simultaneously there is an equivalent change
in cytoplasmic and nucleoplasmic content from the
nucleolus, it is not possible to visualize this change by
plotting the nucleoplasmic/cytoplasmic versus the nucleolar/
cytoplasmic ratios. Thus, we plotted the nucleolar/nucleo-
plasmic ratios before and after DNA damage (Figs. 4E
and F). We observed a redistribution of the ribosomal
proteins following DNA damage in the wild-type cells from
the nucleolus to the nucleoplasm (Fig. 4E). In this case,
most proteins appear below the line line through the origin
on the scatter plot. However, this relocalization did not
occur in the absence of p53 (Fig. 4F) where most proteins
cluster near the line through the origin.
To conﬁrm the change in localization of ribosomal proteins
after DNA damage, we performed both western blots on
cellular fractions and immunoﬂuorescence. Equal amounts of
either total cell lysates (Fig. 5A, lanes 1 and 5) or of extracts
from the cytoplasmic (Fig. 5A, Cyto, lanes 2 and 6), nuclear
Figure 3. DNA damage
response and p53. Visualiza-
tion of the spatial proteomics
data by graphical representa-
tion, plotting the log base
two Nucleoplasmic/Cytoplas-
mic ratio on the x axis and log
base two Nucleolar/Cyto-
plasmic ratio on the y axis of
either mock treated (A) wild-
type and (B) p53 knock-out
cells or of Eto-treated (C) wild-
type and (D) p53 knock-out
cells.
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and 8) fractions of either HCT116 wild-type cells (top) or p53
knock-out (bottom) that were either mock-treated (lanes 1–4)
or treated with 50mM Eto (lanes 5–8) for 1h were separated by
SDS-PAGE and stained with Coomassie Blue to make sure of
equivalent loading of proteins from each fraction. The same
fractions were again separated by SDS-PAGE, but this time
transferred to nitrocellulose prior to western blotting with
either an RPL11 antibody or a B23-nucleophosmin antibody.
RPL11 is observed in both the Cyto and nucleolus in the
absence of DNA damage (Fig. 5B, mock). However, there is a
reduction in the amount of RPL11 located in the nucleolus
following treatment with Eto (Fig. 5B, lane 4). This appears to
coincide with an increase in RPL11 in both the Cyto and the
nucleoplasm, and this increase is not observed in p53 knock-
out cells (Fig. 5B, Eto, lanes 3 and 4). To further demonstrate
this relocalization, HCT116 wild-type (Figs. 6A–F) and p53
knock-out (Figs. 6G–L) cells were cultured on coverslips and
either mock-treated (Figs. 6A–C and Fig. 6G–I) or treated with
50mM Eto (Figs. 6D–F and J–L) for 1h. Cells were then ﬁxed,
permeabilized and labeled for immunoﬂuorescence using an
antibody recognizing RPL11 (Figs. 6B–E and H–K). We did
not detect endogenous RPL11 in the nucleolus in these
experiments despite trying different ﬁxation procedures,
Figure 4. Effect of p53 on the
ribosomal proteins response to
DNA damage. Visualization of
the spatial proteomics data of
ribosomal proteins by graphi-
cal representation, plotting the
log base two Nucleoplasmic/
Cytoplasmic ratio on the x axis
and log base two Nucleolar/
Cytoplasmic ratio on the y axis
of (A) wild-type mock treated
(blue) and wild-type Eto-trea-
ted cells (red), (B) wild-type
mock treated (blue) and p53
knock-out mock treated cells
(red), (C) p53 knock-out mock
treated (blue) and p53 knock-
out Eto-treated cells (red) and
(D) wild-type Eto treated (blue)
and p53 knock-out Eto-treated
cells (red). Visualization of the
spatial proteomics data of
ribosomal proteins by graphi-
cal representation, plotting the
log base two Nucleolar/
Nucleoplasmic ratio of mock-
treated cells on the x axis and
of Eto-treated cells on the
y axis for the (E) wild-type cells
and (F) p53 knock-out cells.
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both the Cyto and the No [22]. This is likely due to failure of
the antibody to penetrate and reach its epitope in the
nucleolus of ﬁxed cells. However, we detected a strong cyto-
plasmic signal by immunoﬂuorescence with the RPL11 anti-
body. There was a difference in the localization of RPL11
following treatment of HCT116 cells with Eto (compare Figs.
6B and E), with an increase in labelling in the nucleus evident
after DNA damage. Again, this relocalization of RPL11 was
not observed in HCT116 cells lacking p53 (compare Figs. 6H
and K). This demonstrates how spatial proteomics can be used
to not only look at individual protein responses under differ-
ent conditions, but also how different groups of proteins can
be analyzed provide an unbiaised understanding of under-
lying functional interactions at a system-wide level.
The proteomic experiments not only provide data show-
ing the relative enrichment of proteins in different subcel-
lular compartments, but they also make it possible to
analyze the ion intensity of proteins in the cell as a
measurement of total protein abundance. Although less
reliable than the SILAC ratios, it still provides an interesting
measure of changes in protein level. We thus analyzed the
intensity values to address whether we could identify
candidate proteins induced following treatment with Eto,
and which of these changes in protein level are dependent
on p53. Approximately 5% (103) of proteins identiﬁed
showed a 4three-fold increase in protein level following
treatment with Eto (Supporting Information Table 4, p.1).
Of those 103 proteins, we found a speciﬁc GO enrichment
in proteins involved in mRNA splicing (12), amino acid
metabolic process (10), intracellular transport (10) and
response to oxidative stress (6). Interestingly, only six of
these proteins were not increased also in the p53 knock-out
cells (Fig. 7A and Supporting Information Table 4, p.2). The
increase in intensity of Phosphoserine phosphatase and the
ATP-dependent DNA helicase Q1 (RecQ1) are shown in
Figs. 7B and C, where the induction of protein after DNA
damage is seen only in wild-type cells. None of those six
proteins have been previously characterized as being p53-
regulated transcriptional targets, although a disctinct role
for RecQ1 has been described in the maintenance of the
genomic stability. RecQ1 catalyzes DNA unwinding and
strand annealing, and these activities are likely to be
important for its role in DNA repair [23].
4 Discussion
In this study we used spatial proteomics as an unbiased and
quantitative MS-based approach to study not only the
Figure 5. Western blot analysis of ribosomal
proteom response. (A) Equal amount (10mg)
of total cell lysates (lanes 1 and 5) or of
extracts from the cytoplasmic (Cyto, lanes 2
and 6), nuclear (Nuc, lanes 3 and 7) or
nucleolar (No, lanes 4 and 8) fractions of
HCT116 wild-type cells (top) or p53 knock-
out (bottom) that were either mock-treated
(1–4) or treated with 50mM Eto for 1h (5–8)
were separated by SDS-PAGE and stained
with Coomassie Blue. The same fractions
were separated by SDS-PAGE, transferred to
nitrocellulose prior to Western blotting with
an RPL11 antibody (B) or a B23-nucleo-
phosmin antibody (C) .
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one gene locus, p53, but also to see the difference in how the
cells respond to DNA damage, a response in which p53 is
involved. We show that there are very few differences in the
overall subcellular localization of proteins that depends on
the p53 gene. This conﬁrms the speciﬁcity of the response
Figure 6. Immunoﬂuorescence analysis of
ribosomal protein response. HCT116 wild-
type (A–F) and p53 knock-out (G–L) were
cultured on coverslips and either mock-
treated (A–C and G–I) or treated with 50mM
Eto (D–F and J–L) for 1h. Cells were then
ﬁxed with 3.7% paraformaldehyde in CSK
buffer for 10min, permeabilized and labeled
for immunoﬂuorescence using an antibody
recognizing RPL11 (B–E–H–K). DNA was
visualized using DAPI (A–D–G–J). Scale bars
represent 15mm.
Figure 7. p53-dependent
protein induced by DNA
damage. Example of two
proteins (Phosphoserine Phos-
phatase and ATP-dependent
DNA helicase Q1) whose
intensity was increased
following Eto treatment in
wild-type cells (compare
intensity WT versus intensity
WTE), but not in p53 knock-out
cells (compare intensity p53
versus intensity p53E).
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p53 is a short-lived protein that is present in cells at a barely
detectable level. Thus, p53 makes little difference to the
subcellular proteome localization under normal growth
conditions. Interestingly, the 40 proteins that showed a
localization difference in the absence of p53 (but without
DNA damage) were mostly proteins involved in splicing,
including most of the members of the core spliceosome (Sm
A, B, D1, D3 and E), as well as several other splicing factors
(SF3A, B, hnRNPs) This may reﬂect a true difference
between those two cell lines in p53-dependent gene
expression and merit further investigation in future.
However, we cannot rule out that the difference in expres-
sion was acquired through secondary mutations as a result
of culturing the two cell lines in parallel for several years [1].
Upon exposure of cells to various forms of exogenous
stress, such as DNA damage, there is a stabilization of p53,
which is then responsible for an ensuing cascade of events,
resulting in either cell cycle arrest or in apoptosis. We
observed a general effect of Eto on the nucleoplasmic/cyto-
plasmic protein ratios, which shows that the response in
both cell lines is generally quite similar for the proteins
shuttling between the Cyto and the nucleus. We found a
notable difference in the nucleolar/cytoplasmic ratios
following DNA damage, whether p53 is present or not. In
wild-type cells, p53 appears to cause a shut-down of
nucleolar activity, which results in a speciﬁc segregation of
nucleolar proteins within the nucleolus. However, this
seems to be dependent on p53, as the effect is observed to a
much lesser extent in p53 knock-out cells. One such
consequence is that the ribosomal proteins are no longer
accumulating in the nucleolus following DNA damage. This
suggest a possible early role for p53 in shutting down the
rDNA transcription machinery, as well as either stopping
the nucleolar recruitment, or retention of ribosomal
proteins in the nucleolus, indicating that cells undergo a
rapid stop in ribosome subunit production following DNA
damage. Several recent reports showed that p53 becomes
activated after silencing of ribosomal proteins such as
RPL23 [24], RPL11 [25], RPS6 [26] and TIF1A [27]. Other
evidence emerging from a number of mouse models
support the existence of this ribosomal dependent p53
checkpoint in vivo [28]. During normal cellular growth,
ribosomal proteins are assembled into ribosomal subunits,
but several ribosomal proteins (RPL11, RPL5, RPL23, RPS7
and RPS9) have now been shown to be released from the
nucleolus following stress and to bind HDM2, resulting in
stabilization of p53 [28–31]. Our data suggest that p53 is
actually necessary for the initial release of ribosomal
proteins from the nucleolus following stress, and that this
release probably results in an ampliﬁcation of the p53
response through stabilization by preventing HDM2-medi-
ated degradation of p53.
Cell growth is essential for cell cycle progression and the
attainment of a particular cell mass is a prerequisite for cell
division. As ribosome levels reﬂect the capacity of the cell to
grow and achieve this cell mass, it is possible that ribosome
subunit production in the nucleolus plays an important role
in controlling cell cycle progression. Another important link
between the fate of the cell and the level of ribosome subunit
biogenesis has been demonstrated from the observation that
events that perturb the structure or function of the nucleo-
lus, the center of rDNA transcription and ribosome subunit
production, can cause p53 accumulation [5, 32], which can
lead to cell cycle arrest or apoptosis [1]. Because such events
produce a negative effect on rRNA transcription, it is
possible that the levels of rRNA are directly inﬂuenced by
p53 accumulation and the decision to trigger cell cycle
arrest, or even apoptosis [33]. In addition, the repetitive
nature of the rRNA genes, in combination with the dense
loading of the RNA polymerase I complexes on the active
templates, provides a potential sensor for DNA damage. The
ampliﬁcation of signals associated with stalled polymerases
and/or reduced rRNA levels could further activate p53 and
other DNA-damage response pathways.
The spatial proteomics method used here allowed us to
characterize how cells respond differently depending on the
presence of a single, albeit very important, protein in
response to DNA damage. It has provided accurate infor-
mation at a proteome-wide level of the speciﬁc effect, and
has allowed us to characterize more precisely how cells
respond to exposure to Eto. It will be interesting in the
future to analyze also the post-translational modiﬁcations
that change under different conditions. The spatial proteo-
mics approach complements other methods and can be
used to further analyze and independently verify data from
microscopy and molecular studies that are not readily
applicable in high throughput. We envisage that spatial
proteomics can be used to characterize a wide range of
different cell types and can be combined with alternative
fractionation techniques to analyze multiple subcellular
compartments and structures.
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